Clinical trial
A Multicentre, Comparative, Randomised, Double-blind, Double-dummy Clinical Trial on the Efficacy and Safety of Condrosulf Versus Celebrex and Versus a Placebo in the Treatment of Knee Osteoarthritis
NCT02079727 is registered in ClinicalTrials.gov with IBSA Institut Biochimique SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre, Comparative, Randomised, Double-blind, Double-dummy Clinical Trial on the Efficacy and Safety of Condrosulf Versus Celebrex and Versus a Placebo in the Treatment of Knee Osteoarthritis
- Lead sponsor
- IBSA Institut Biochimique SA
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 12, 2014
- Completion date
- June 16, 2016
- Enrollment
- 604 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
knee osteoarthritis